Back to 
CITADEL ADVISORS LLC
CITADEL ADVISORS LLC
KLRA1 quarters
Position history for CITADEL ADVISORS LLC's holdings in KAILERA THERAPEUTICS INC
Yes. Citadel Advisors holds 3,240,787 shares of KLRA (Kailera Therapeutics), worth $71.4M, as of its Q2 2026 13F filing.
Current Value
$71.4M
Current Shares
3.2M
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of KLRA: RTW INVESTMENTS, LP, CANADA PENSION PLAN INVESTMENT BOARD, FMR LLC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/